查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1970475

全球心內和血管內超音波市場規模、佔有率、趨勢和成長分析報告（2026-2034）

Global Intracardiac Echocardiography and Intravascular Ultrasound Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 114 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計到 2034 年，心臟內超音波超音波和血管內超音波的市場規模將從 2025 年的 10.2 億美元成長到 16.8 億美元，2026 年至 2034 年的複合年成長率為 5.62%。

心內超音波心臟檢查和血管內超音波（IVUS）技術正融合成為下一代介入性心臟病學中不可或缺的影像技術。心內超音波心動圖（ICE）可提供即時、高解析度的心內影像，簡化複雜的結構性心臟介入手術流程。這減少了對透視的依賴，並提高了手術的精確度。 IVUS能夠以亞毫米級的解析度解析血管壁形態和斑塊成分，從而在經皮冠狀動脈和周邊血管介入治療過程中實現支架尺寸的選擇、最佳化以及病變形態的評估。這些技術協同作用，基於生理引導進行影像主導的決策，創造新的手術流程，最終改善治療效果並縮短手術時間。隨著微創結構性心臟病治療的日益普及，對整合ICE、IVUS及其他輔助影像技術的整合式影像平台的需求必將持續成長。

技術進步進一步提升了其臨床效用。高頻換能器、導管小型化和自適應波束形成技術的改進提高了空間解析度並縮小了導管尺寸，從而便於進入彎曲的解剖結構。融合成像、自動斑塊定量和3D重建等軟體技術的進步，將原始數據轉化為介入性外科醫生可操作的指標。此外，內建人工智慧演算法能夠實現即時組織表徵、分割和引導支持，從而減少操作者差異並加快術中決策。與導管室資訊系統的整合以及與機器人導航平台的互通性，將進一步鞏固ICE/IVUS在現代混合手術環境中的關鍵地位。

商業化部署將由實證醫學證據的累積和適應症的擴展所驅動。隨著註冊研究和隨機對照試驗量化了合理應用ICE/IVUS可降低輻射曝射量、手術併發症和長期血管再阻塞，預計其應用範圍將從三級醫療機構擴展到社區醫療中心。納入減少再次介入和縮短恢復時間的成本效益模型將促使支付方接受該技術，同時，旨在提升介入性心臟病專家和導管檢查室團隊技能的培訓課程也在不斷發展完善。遠距教學和遠端圖像判讀服務也蘊藏著機會。血管內影像專家的評估將有助於將先進的醫療服務擴展到資源匱乏的地區。總而言之，ICE和IVUS正從輔助設備發展成為標準的治療影像工具，以實現更安全、更有效的血管內和結構性心臟疾病治療。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球心內及血管內超音波市場：依應用領域分類

  • 市場分析、洞察與預測
  • 電生理治療
  • 左心耳閉鎖
  • 室間隔缺損
  • 其他

第5章 全球心內和血管內超音波市場：依最終用途分類

  • 市場分析、洞察與預測
  • 醫院
  • 導管檢查室
  • 其他

第6章 全球心內及血管內超音波市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Johnson & Johnson Services Inc.（Biosense Webster Inc.）
    • Nipro（Infraredx Inc.）
    • Conavi Medical
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • GE HealthCare
    • Medtronic Plc
    • Canon Medical Systems Corp
簡介目錄
Product Code: VMR11215985

The Intracardiac Echocardiography and Intravascular Ultrasound Market size is expected to reach USD 1.68 Billion in 2034 from USD 1.02 Billion (2025) growing at a CAGR of 5.62% during 2026-2034.

Intracardiac echocardiography and intravascular ultrasound technologies are converging as indispensable imaging modalities for next-generation interventional cardiology. ICE provides real-time, high-resolution intracardiac views that streamline complex structural heart interventions-reducing reliance on fluoroscopy and improving procedural precision. IVUS offers sub-millimeter resolution of vessel wall morphology and plaque composition, enabling accurate stent sizing, optimization, and assessment of lesion morphology during percutaneous coronary and peripheral interventions. Together, these modalities are redefining procedural workflows by enabling physiology-guided, image-driven decision making that improves outcomes and shortens procedure times. As minimally invasive structural therapies proliferate, demand for integrated imaging platforms that combine ICE, IVUS, and adjunctive modalities will intensify.

Technical innovation is driving deeper clinical utility. Advances in high-frequency transducers, catheter miniaturization, and adaptive beamforming are improving spatial resolution while reducing catheter profiles-facilitating access to tortuous anatomy. Software advances such as fusion imaging, automated plaque quantification, and 3D reconstruction are transforming raw data into actionable metrics for interventionalists. Additionally, onboard AI algorithms are beginning to assist in real-time tissue characterization, segmentation, and guidance cues, reducing inter-operator variability and accelerating intra-procedural decisions. Integration with catheter lab information systems and interoperability with robotic navigation platforms will further anchor ICE/IVUS as critical components of the modern hybrid operating environment.

Commercial expansion will be propelled by evidence generation and expanded indications. As registries and randomized studies quantify reductions in radiation exposure, procedural complications, and long-term restenosis when ICE/IVUS is applied judiciously, adoption across tertiary and community centers will broaden. Cost-benefit models that incorporate reduced re-interventions and faster recovery will support payer acceptance, while training curricula evolve to upskill interventional cardiologists and cath lab teams. Opportunities also exist in tele-mentoring and remote interpretation services, where expert review of intravascular imaging can extend advanced care to underserved regions. Overall, ICE and IVUS are positioned to move from niche adjuncts to standard-of-care imaging tools enabling safer, more effective endovascular and structural heart therapies.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

  • Electrophysiology Procedures
  • Left Atrial Appendage Closure
  • Septal Defects
  • Others

By End-Use

  • Hospitals
  • Catheterization Laboratories
  • Others

COMPANIES PROFILED

  • Abbott Laboratories, Boston Scientific Corporation, Johnson Johnson Services Inc Biosense Webster Inc, Nipro Infraredx Inc, Conavi Medical, Siemens Healthineers AG, Koninklijke Philips NV, GE HealthCare, Medtronic plc, Canon Medical Systems Corp
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL INTRACARDIAC ECHOCARDIOGRAPHY AND INTRAVASCULAR ULTRASOUND MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Application
  • 4.2. Electrophysiology Procedures Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Left Atrial Appendage Closure Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Septal Defects Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL INTRACARDIAC ECHOCARDIOGRAPHY AND INTRAVASCULAR ULTRASOUND MARKET: BY END-USE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast End-use
  • 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Catheterization Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL INTRACARDIAC ECHOCARDIOGRAPHY AND INTRAVASCULAR ULTRASOUND MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Application
    • 6.2.2 By End-use
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Application
    • 6.3.2 By End-use
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Application
    • 6.4.2 By End-use
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Application
    • 6.5.2 By End-use
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Application
    • 6.6.2 By End-use
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL INTRACARDIAC ECHOCARDIOGRAPHY AND INTRAVASCULAR ULTRASOUND INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Abbott Laboratories
    • 8.2.2 Boston Scientific Corporation
    • 8.2.3 Johnson & Johnson Services Inc. (Biosense Webster Inc.)
    • 8.2.4 Nipro (Infraredx Inc.)
    • 8.2.5 Conavi Medical
    • 8.2.6 Siemens Healthineers AG
    • 8.2.7 Koninklijke Philips N.V
    • 8.2.8 GE HealthCare
    • 8.2.9 Medtronic Plc
    • 8.2.10 Canon Medical Systems Corp